Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Bionovo |
---|---|
Information provided by: | Bionovo |
ClinicalTrials.gov Identifier: | NCT00453089 |
To conduct a prospective, randomized, blinded, placebo controlled, dose escalation clinical trial in 4 cohorts of 10 postmenopausal women (total N=40) aged 45 to 65 years with at least one menopausal vaginal symptom, vaginal pH > 5.0 and > 20% parabasal vaginal epithelial cells.
Condition | Intervention | Phase |
---|---|---|
Vaginal Atrophy Vulvar Atrophy |
Drug: VG101 |
Phase I Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Phase I/II Dose Escalation Clinical Trial to Assess Safety and Efficacy of VG101 to Treat the Symptoms of Vulvar and Vaginal Atrophy in Post-Menopausal Women |
Estimated Enrollment: | 40 |
Study Start Date: | June 2010 |
Estimated Study Completion Date: | August 2011 |
Estimated Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |
Primary Aims:
Secondary Aims:
the preliminary efficacy of VG101 to:
Ages Eligible for Study: | 45 Years to 65 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Self-report at least one moderate to severe symptom of vulvar or vaginal atrophy from the following list:
Exclusion Criteria:
Contact: Azin Olyaie, MS | (510) 420-4163 | azin.olyaie@bionovo.com |
United States, Alabama | |
University of Alabama, Birmingham | |
Birmingham, Alabama, United States, 35294 | |
United States, California | |
University of California, San Francisco | |
San Francisco, California, United States, 94115 |
Principal Investigator: | Mary Tagliaferri, MD | Bionovo, Inc |
Responsible Party: | Bionovo, Inc ( Mary Tagliaferri, MD ) |
Study ID Numbers: | VG-101-001 |
Study First Received: | March 26, 2007 |
Last Updated: | August 21, 2009 |
ClinicalTrials.gov Identifier: | NCT00453089 History of Changes |
Health Authority: | United States: Institutional Review Board |
Chinese Herbs Postmenopausal Vaginal Atrophy Vulvar Atrophy |
Symptoms Bionovo VG101 |
Pathological Conditions, Anatomical Atrophy Marijuana Abuse Menopause |
Pathological Conditions, Anatomical Atrophy |